Assetmark, Inc Amneal Pharmaceuticals, Inc. Transaction History

Assetmark, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$6.44 - $14.29 $9,627 - $21,363	-1,495 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$11.87 - $14.84 $439 - $549	-37 Reduced 2.42%	1,495 $21,000
Q4 2018 Feb 13, 2019	SELL	$13.09 - $21.49 $4,084 - $6,704	-312 Reduced 16.92%	1,532 $21,000
Q3 2018 Nov 13, 2018	SELL	$16.4 - $24.27 $147 - $218	-9 Reduced 0.49%	1,844 $41,000
Q2 2018 Aug 01, 2018	BUY	$13.95 - $20.2 $25,849 - $37,430	1,853 New	1,853 $30,000

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.